参考文献/References:
[1] KWON-CHUNG K J, SUGUI J A. Aspergillusfumigatus--what makes the species a ubiquitous humanfungal pathogen[J]. PLoS Pathogens, 2013, 9(12):e1003743.
[2] 徐媛，陈敏，廖万清．中国侵袭性曲霉菌病流行病学现状[J]．中国真菌学杂志，2018，13（1）：57-60． XU Yuan, CHEN Min, LIAO Wanqing. Epidemiologyof invasive Aspergillosis in China [J]. Chinese Journalof Mycology, 2018,13(1):57-60.
[3] 马梦亭，王凤超．临床患者血流真菌感染的实验诊断及治疗研究进展[J]．现代检验医学杂志，2019，34（4）：161-164． MA Mengting, WANG Fengchao. Advances inexperimental diagnosis and treatment of blood flowfungal infection in clinical patients [J]. Journal ofModern Laboratory Medicine, 2019,34(4):161-164.
[4] 娄鉴芳，梅亚宁，张世昌，等．不同实验室环境下ELISA 法检测血清GM 结果的可靠性研究[J]．现代检验医学杂志，2019，34（1）：101-103． LOU Jianfang, MEI Yaning， ZHANG Shichang, etal. Reliability study on serum GM results by ELISAmethod in different laboratory conditions [J]. Journal ofModern Laboratory Medicine, 2019,34(1):101-103.
[5] RIVERO-MENENDEZ O, ALASTRUEY-IZQUIERDOA, MELLADO E, et al. Triazole resistance in Aspergillusspp: A worldwide problem?[J]. Journal of Fungi(Basel, Switzerland), 2016, 2(3): 21.
[6] SHISHODIA S K, TIWARI S, SHANKAR J. Resistancemechanism and proteins in Aspergillus species againstantifungal agents[J]. Mycology, 2019, 10(3): 151-165.
[7] MISCH E A, SAFDAR N. Updated guidelines for thediagnosis and management of Aspergillosis[J]. Journalof Thoracic Disease, 2016, 8(12): E1771-E1776.
[8] 张丽，王贺，肖盟，等．E-test 方法与微量肉汤稀释法检测念珠菌属对唑类抗真菌药物的敏感性评价[J]. 现代检验医学杂志，2019，34（4）：67-70． ZHANG Li , WANG He, XIAO Meng, et al .Comparison of E-test and broth microdilution methodfor antifungal susceptibility testing of Candida speciesto azoles [J]. Journal of Modern Laboratory Medicine,2019,34(4):67-70.
[9] 陈勇，韩黎．深部真菌医院感染及其耐药性现状[J].中国消毒学杂志，2016，33（4）：372-375． CHEN Yong, HAN Li. Nosocomial infections ofdeep fungi and their drug resistance status[J]. ChineseJournal of Disinfection. 2016,33(4):372-375.
[10] CANNON R D, LAMPING E, HOLMES A R, et al. Efflux-mediated antifungal drug resistance[J]. ClinicalMicrobiology Reviews, 2009, 22(2): 291-321.
[11] CHAMILOS G, KONTOYIANNIS D P. Update onantifungal drug resistance mechanisms of Aspergillusfumigatus[J]. Drug Resistance Updates, 2005, 8(6): 344-358.
[12] TOBIN M B, PEERY R B, SKATRUD P L. Genes encodingmultiple drug resistance-like proteins in Aspergillusfumigatus and Aspergillus flavus[J]. Gene, 1997,200(1/2): 11-23.
[13] SLAVEN J W, ANDERSON M J, SANGLARD D, et al.Increased expression of a novel Aspergillus fumigatusABC transporter gene, atrF, in the presence of itraconazolein an itraconazole resistant clinical isolate[J].Fungal Genetics and Biology, 2002, 36(3): 199-206.
[14] NASCIMENTO A M, GOLDMAN G H, PARK S, etal. Multiple resistance mechanisms among Aspergillusfumigatus mutants with high-level resistance to itraconazole[J]. Antimicrobial Agents and Chemotherapy,2003, 47(5): 1719-1726.
[15] RAJENDRAN R, MOWAT E, MCCULLOCH E, etal. Azole resistance of Aspergillus fumigatus biofilmsis partly associated with efflux pump activity[J].Antimicrobial Agents and Chemotherapy, 2011, 55(5):2092-2097.
[16] SUN Nuo, LI Dongmei, FONZI W, et al. Multidrugresistanttransporter mdr1p-mediated uptake of a novelantifungal compound[J]. Antimicrobial Agents andChemotherapy, 2013, 57(12): 5931-5939.
[17] PAUL S, LUDE?A Y, VILLENA G K, et al. Highqualitydraft genome sequence of a biofilm forminglignocellulolytic Aspergillus higer strain ATCC 10864[J].Standards in Genomic Sciences, 2017, 12(1): 37.
[18] KAUR S, SINGH S. Biofilm formation by Aspergillusfumigatus[J]. Medical Mycology, 2014, 52(1): 2-9.
[19] MOWAT E, BUTCHER J, LANG S, et al. Developmentof a simple model for studying the effects of antifungalagents on multicellular communities of Aspergillusfumigatus[J]. Journal of Medical Microbiology, 2007,56(Pt 9): 1205-1212.
[20] BEAUVAIS A, SCHMIDT C, GUADAGNINI S, etal. An extracellular matrix glues together the aerialgrownhyphae of Aspergillus fumigatus[J]. CellularMicrobiology, 2007, 9(6): 1588-1600.
[21] 喻玮，楼亚玲，裘云庆，等．曲霉菌对唑类抗真菌药物的耐药机制研究进展[J]．中国抗生素杂志，2018，43（7）：801-805． YU Wei, LOU Yaling, QIU Yunqing, et al. Researchprogress on the mechanism of Aspergillus fungiresistant to azoles family antifugal agents [J]. ChineseJournal of Antibiotics,2018,43(7):801-805.
[22] LINDEN J W, ARENDRUP M C, WARRIS A, et al.Prospective multicenter international surveillance ofazole resistance in Aspergillus fumigatus[J]. EmergingInfectious Diseases, 2015, 21(6): 1014-1041.
[23] SNELDERS E, KARAWAJCZYK A, SCHAFTENAARG, et al. Azole resistance profile of amino acid changesin Aspergillus fumigatus CYP51A based on proteinhomology modeling[J]. Antimicrobial Agents andChemotherapy, 2010, 54(6): 2425-2430.
[24] CHOWDHARY A, SHARMA C, HAGEN F, et al. Exploringazole antifungal drug resistance in Aspergillusfumigatus with special reference to resistance mechanisms[J]. Future Microbiology, 2014, 9(5): 697-711.
[25] WARRILOW A G, MELO N, MARTEL C M, et al.Expression, purification, and characterization of Aspergillusfumigatus sterol 14-alpha demethylase (CYP51)isoenzymes A and B[J]. Antimicrobial Agents and Chemotherapy,2010, 54(10): 4225-4234.
[26] BUIED A, MOORE C B, DENNING D W, et al. Highlevelexpression of cyp51B in azole-resistant clinicalAspergillus fumigatus isolates[J]. The Journal ofAntimicrobial Chemotherapy, 2013, 68(3): 512-514.
[27] HORTSCHANSKY P, ANDO E, TUPPATSCH K, et al.Deciphering the combinatorial DNA-binding code ofthe CCAAT-binding complex and the iron-regulatorybasic region leucine zipper (bZIP) transcription factorHapX[J]. The Journal of Biological Chemistry, 2015,290(10): 6058-6070.
[28] CAMPS S M, DUTILH B E, ARENDRUP M C, etal. Discovery of a HapE mutation that causes azoleresistance in Aspergillus fumigatus through wholegenome sequencing and sexual crossing[J]. PLoS One,2012, 7(11): e50034.
[29] GSALLER F, HORTSCHANSKY P, FURUKAWA T, etal. Sterol biosynthesis and azole tolerance is governed bythe opposing actions of SrbA and the CCAAT bindingcomplex[J]. PLoS Pathogens, 2016, 12(7): e1005775.
[30] 陈先华，牛军，郝飞．烟曲霉菌对唑类抗真菌药的耐药机制研究进展[J]．中华临床医师杂志（电子版），2016，10（3）：418-423． CHEN Xianhua, NIU Jun, HAO Fei. Progress inthe mechanisms of azole antifungal drug resistancein Aspergillus fumigatus [J]. Chinese Journal ofClinicians(Electronic Edition), 2016,10(3):418-423.
[31] CHEN Yong, LU Zhongyi, ZHAO Jingjun, et al. Epidemiologyand molecular characterizations of azoleresistance in clinical and environmental Aspergillusfumigatus isolates from China[J]. Antimicrobial Agentsand Chemotherapy, 2016, 60(10): 5878-5884.
[32] HAGIWARA D, TAKAHASHI H, FUJIMOTO M, etal. Multi-azole resistant Aspergillus fumigatus harboringCyp51A TR46/Y121F/T289A isolated in Japan[J]. Journalof Infection and Chemotherapy, 2016, 22(8): 577-579.
[33] LAMOTH F, JUVVADI P R, FORTWENDEL J R, etal. Heat shock protein 90 is required for conidiationand cell wall integrity in Aspergillus fumigatus[J].Eukaryotic Cell, 2012, 11(11): 1324-1332.
[34] XIONG Quanbo, HASSAN S A, WILSON W K, et al.Cholesterol import by Aspergillus fumigatus and itsinfluence on antifungal potency of sterol biosynthesisinhibitors[J]. Antimicrobial Agents and Chemotherapy,2005, 49(2): 518-524.
[35] WILLGER S D, PUTTIKAMONKUL S, KIM K , et al.A sterol-regulatory element binding protein is requiredfor cell polarity, hypoxia adaptation, azole drugresistance, and virulence in Aspergillus fumigatus[J].PLoS Pathogens, 2008, 4(11): e100020.